$8.48 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 6 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DSEY | DIVERSEY HLDGS LTD | $3,791,056,000 | -10.4% | 236,350,134 | 0.0% | 44.71% | +8.2% | |
| SGRY | SURGERY PARTNERS INC | $2,077,394,000 | -36.4% | 49,064,576 | 0.0% | 24.50% | -23.2% | |
| CERE | CEREVEL THERAPEUTICS HLDNG, INC. | $1,788,655,000 | +15.1% | 60,632,356 | 0.0% | 21.09% | +39.1% | |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | $649,858,000 | -35.2% | 81,029,675 | 0.0% | 7.66% | -21.7% | |
| IQV | IQVIA HLDGS INC | $147,912,000 | -1.1% | 617,484 | 0.0% | 1.74% | +19.4% | |
| ADV | ADVANTAGE SOLUTIONS INC | $24,999,000 | -19.8% | 2,890,000 | 0.0% | 0.30% | -3.0% | |
| Exit | ATENTO S A | $0 | – | -156,574 | -100.0% | -0.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners X, L.P. #1
- Bain Capital Fund X, L.P. #2
- Bain Capital Integral Investors 2008, L.P. #3
- Bain Capital Partners Europe III, L.P. #4
- Bain Capital Europe Fund III, L.P. #5
- Bain Capital Integral Investors 2006, LLC #6
- Atalaya Luxco S.a.r.l. #7
- Atalaya Luxco Topco S.C.A. #8
- Atalaya PIKco S.a r.l. #9
- Atalaya Luxco PIKco S.C.A #10
- BCPE Seminole GP LLC #11
- BCPE Seminole Holdings LP #12
- Bain Capital Partners XII, LLC #13
- Bain Capital Fund XII, LP #14
- BCPE Perception GP, LLC #15
- BC Perception Holdings, LP #16
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-21 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-18 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-06 |
| 4 | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.